Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a ...

Recursion Pharmaceuticals (NASDAQ:RXRX) is a TechBio using its Recursion OS platform, which leverages AI to aid drug ...

We are paying the highest drug prices in the world. Americans can’t continue to afford it,” CT Sen. Matt Lesser said.

A new bladder cancer device called TAR-200 kept most patients cancer-free and surgery-free in a trial, with few side effects ...

Revenue-- $564,000 in revenue for fiscal Q2 2025 (period ended June 30, 2025), down from $901,000 in fiscal Q2 2024, reflecting a reduction attributed to lower procedure volumes and a shift in ...